Abstract:Most agents that damage DNA act through posttranslational modifications of p53 and activate its downstream targets. However, whether cellular responses to nucleoside analogue-induced DNA damage also operate through p53 posttranslational modification has not been reported. In this study, the relationship between p53 activation and its posttranslational modifications was investigated in the human cancer cell lines A549 and HCT116 in response to 5-aza-2 '-deoxycytidine (5-aza-CdR) or cytarabine treatment. 5-Aza-CdR induces p53 posttranslational modifications through activation of an ATM- and Rad3-related (ATR) signaling pathway, and 5-aza-CdR-induced association of replication protein A with chromatin is required for the binding of ATR to chromatin. Upon treatment with 5-aza-CdR, ATR activation is clearly associated with p53 phosphorylation at Ser(15), but not at Thr(18), Ser(20), or Ser(37). This specific p53 phosphorylation at Ser15 in turn results in acetylation of p53 at Lys(320) and Lys(373)/Lys(382) through transcriptional cofactors p300/CBP-associated factor and p300, respectively. These p53 posttranslational modifications are directly responsible for 5-aza-CdR induced p21(Waf1/Cip1) expression because the binding activity of acetylated p53 at Lys(320)/Lys(373)/ Lys(382) to the p21(Waf1/Cip1) promoter, as well as p21(Waf1/Cip1) expression itself are significantly increased after 5-aza-CdR treatment. It is of interest that p53 phosphorylation at Ser15 and acetylations at Lys(320)/Lys(373)/ Lys382 mutually interact in the 5-aza-CdR induced p21(Waf1)/(Cip1) expression shown by transfection of artificially mutated p53 expression vectors including S15A, K320R, and K373R/K382 into p53-null H1299 cells. These data taken together show for the first time that 5-aza-CdR activates the ATR signaling pathway, which elicits a specific p53 phosphorylation-acetylation cascade to induce p21(Waf1/Cip1) expression.

A Newly Identified Dependence Receptor UNC5H4 is Induced During DNA Damage-Mediated Apoptosis and Transcriptional Target of Tumor Suppressor P53.

P53 and P21(waf1) Are Recruited to Distinct PML-Containing Nuclear Foci in Irradiated and Nutlin-3a-Treated U2OS Cells

The Nuclear Function of P53 is Required for Puma-Mediated Apoptosis Induced by Dna Damage

Differential Regulation of Apak by Various Dna Damage Signals

E2F1 Regulates P53r2 Gene Expression in P53-Deficient Cells

Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.

PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage

The P53-Induced Oncogenic Phosphatase PPM1D Interacts with Uracil DNA Glycosylase and Suppresses Base Excision Repair.

Regulation of PUMA- α by p53 in cisplatin-induced renal cell apoptosis

Data from Ribosomal Protein S27-like, a p53-Inducible Modulator of Cell Fate in Response to Genotoxic Stress

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

P53 Deficiency-Induced Smad1 Upregulation Suppresses Tumorigenesis and Causes Chemoresistance in Colorectal Cancers.

G-Protein-Coupled Receptor Kinase 5 Phosphorylates P53 and Inhibits Dna Damage-Induced Apoptosis

UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation

An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of P53/p21waf1/cip1 in Response to 5-Aza-2′-deoxycytidine Treatment

PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response

Ser18 and Ser23 phosphorylation plays synergistic roles in activating p53-dependent neuronal apoptosis.

DNA-dependent Protein Kinase-independent Activation of p53 in Response to DNA Damage

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage

Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage

Regulation of the DNA damage response by p53 cofactors.